Background: The filaggrin gene (FLG) plays a role in skin diseases, with the skin barrier function being impaired in FLG null carriers. The role of FLG status in relation to nickel penetration into the skin remains unclear.
Objectives: To elucidate the association between FLG status and nickel penetration into stratum corneum (SC) in individuals without self-reported history of nickel allergy.
Methods: Forty participants (23 FLG wt and 17 FLG null) were exposed to a nickel solution (80 μg/cm ) which was applied onto 2 × 2 cm on their left forearm. After 4 h, the area was tape-stripped with 10 consecutive tapes. Nickel in each tape was quantified using inductively coupled plasma mass spectrometry.
Results: The average recovered nickel dose was 35%-48%. A tendency towards lower recovery was seen in FLG null carriers compared to FLG wt carriers, and lower recovery in those with history of skin and/or respiratory symptoms compared to those without such history. This was however not statistically significant.
Conclusion: FLG null carriers had less nickel recovered by tape strips compared with FLG wt carriers and, compared with individuals without a history of skin and/or respiratory symptoms, indicating higher nickel penetration into SC for FLG null carriers, but further studies are needed.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9544599 | PMC |
| http://dx.doi.org/10.1111/cod.14137 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Imputation provides an opportunity to study filaggrin ( ) null mutations in large population cohorts that lack bespoke genotyping.
Wellcome Open Res
May 2024
2. Centre for Genomics and Experimental Medicine, Institute for Genetics and Cancer, University of Edinburgh, Edinburgh, EH4 2XU, UK.
Background: Null mutations within the filaggrin ( ) gene are established genetic risk factors for atopic dermatitis. Studies of have typically used sequencing or bespoke genotyping. Large-scale population cohorts with genome-wide imputed data offer powerful genetic analysis opportunities, but bespoke genotyping is often not feasible in such studies.
View Article and Find Full Text PDFFilaggrin-Associated Atopic Skin, Eye, Airways, and Gut Disease, Modifying the Presentation of X-Linked Reticular Pigmentary Disorder (XLPDR).
J Clin Immunol
January 2024
School of Clinical Medicine, Faculty of Medicine and Health, UNSW Sydney, Sydney, Australia.
Article Synopsis
- X-linked reticular pigmentary disorder (XLPDR) is a rare genetic condition that leads to skin hyperpigmentation, multi-organ inflammation, and immune issues, primarily linked to a specific variant in the POLA1 gene on the X chromosome.
- A case study of a 9-year-old boy revealed symptoms such as eczema, recurrent infections, and growth failure, but he showed improvement in some symptoms over time without treatment.
- Whole-genome sequencing confirmed the diagnosis of XLPDR and identified another variant linked to skin issues, with elevated type 1 interferon activity indicating immune dysfunction in the patient compared to healthy individuals.
Inflammation-related proteins in blood after dermal exposure to some common chemicals depend on the skin barrier gene filaggrin - a human experimental study.
Environ Toxicol Pharmacol
January 2024
Division of Occupational and Environmental Medicine, Department of Laboratory Medicine, Lund University, Lund, Sweden; Unit of Metals and Health, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden. Electronic address:
Filaggrin (FLG), a skin barrier protein, is associated with higher dermal uptake of some chemicals in carriers of loss-of-function (null) mutations. This study investigates FLG mutations and systemic effects following dermal exposure to chemicals. Individuals (n = 23 FLG null, n = 31 FLG wt) were simultaneously exposed to pyrimethanil, pyrene, oxybenzone, and nickel ions for 4 h.
View Article and Find Full Text PDFanalysis of the profilaggrin sequence indicates alterations in the stability, degradation route, and intracellular protein fate in filaggrin null mutation carriers.
Front Mol Biosci
May 2023
Experimental and Translational Immunology Group, Intercollegiate Faculty of Biotechnology of University of Gdansk and Medical University of Gdansk, University of Gdansk, Gdansk, Poland.
Loss of function mutation in is the major genetic risk factor for atopic dermatitis (AD) and other allergic manifestations. Presently, little is known about the cellular turnover and stability of profilaggrin, the protein encoded by . Since ubiquitination directly regulates the cellular fate of numerous proteins, their degradation and trafficking, this process could influence the concentration of filaggrin in the skin.
View Article and Find Full Text PDFFilaggrin gene polymorphisms in Indian children with atopic dermatitis: A cross-sectional multicentre study.
Indian J Dermatol Venereol Leprol
November 2023
Department of Dermatology, Ramaiah Medical College and Hospital, Bengaluru, Karnataka, India.
Background Filaggrin (FLG) gene encoding the protein filaggrin plays an important role in barrier function of the skin and its alteration is a predisposing factor for atopic dermatitis. FLG gene variants result in absent or decreased filaggrin protein. Worldwide, the prevalence of FLG variants ranges from 14 to 56%.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!